- Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. Lordick, F., Ehlken, B., Ihbe-Heffinger, A., Berger, K., Krobot, K.J., Pellissier, J., Davies, G., Deuson, R. Eur. J. Cancer (2007)